Clinical trial
An Investigation Into the Short Term Effect of APOMINE in Patients With…
NCT00078026 · Genzyme, a Sanofi Company, Industry · Terminated
Key facts
| NCT number | NCT00078026 |
|---|---|
| Title | An Investigation Into the Short Term Effect of APOMINE in Patients With Osteoporosis or Low Bone Mass |
| Official title | A Phase I/II Randomized Study of the Short-Term Effects of APOMINE vs Placebo in Postmenopausal Women With Osteoporosis or Low Bone Mass |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Apomine |
| Enrollment | 60 |
| Start date | Aug 1, 2003 |
| Completion | Dec 1, 2004 |
| First posted | Feb 19, 2004 |
| Last update posted | Feb 5, 2014 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: